- Home
- ALLT vs RCKT Comparison
ALLT vs RCKT Comparison
Compare ALLT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- RCKT
- Stock Information
- Founded
- ALLT 1996
- RCKT 1999
- Country
- ALLT Israel
- RCKT United States
- Employees
- ALLT N/A
- RCKT N/A
- Industry
- ALLT Telecommunications Equipment
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- ALLT Telecommunications
- RCKT Health Care
- Exchange
- ALLT Nasdaq
- RCKT Nasdaq
- Market Cap
- ALLT 342.5M
- RCKT 328.6M
- IPO Year
- ALLT 2006
- RCKT N/A
- Fundamental
- Price
- ALLT $7.86
- RCKT $3.28
- Analyst Decision
- ALLT Buy
- RCKT Buy
- Analyst Count
- ALLT 1
- RCKT 13
- Target Price
- ALLT N/A
- RCKT $12.96
- AVG Volume (30 Days)
- ALLT 535.2K
- RCKT 6.0M
- Earning Date
- ALLT 08-14-2025
- RCKT 08-07-2025
- Dividend Yield
- ALLT N/A
- RCKT N/A
- EPS Growth
- ALLT N/A
- RCKT N/A
- EPS
- ALLT N/A
- RCKT N/A
- Revenue
- ALLT $95,342,000.00
- RCKT N/A
- Revenue This Year
- ALLT $10.64
- RCKT N/A
- Revenue Next Year
- ALLT $15.76
- RCKT $108.43
- P/E Ratio
- ALLT N/A
- RCKT N/A
- Revenue Growth
- ALLT 4.74
- RCKT N/A
- 52 Week Low
- ALLT $2.75
- RCKT $2.19
- 52 Week High
- ALLT $10.77
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- ALLT 51.18
- RCKT 51.17
- Support Level
- ALLT $7.71
- RCKT $2.88
- Resistance Level
- ALLT $8.10
- RCKT $3.74
- Average True Range (ATR)
- ALLT 0.44
- RCKT 0.27
- MACD
- ALLT 0.09
- RCKT 0.02
- Stochastic Oscillator
- ALLT 59.12
- RCKT 35.43
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.